Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Rice

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
European Journal of Haematology|August 2, 2003
Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failuresSandeep Kodityal, Amit H Manhas, Mark Udden, et al.
Clinical Therapeutics|May 4, 2010
Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosisJames N Frame, Lawrence Rice, John R Bartholomew, et al.
Annals of Internal Medicine|February 6, 2002
Delayed-onset heparin-induced thrombocytopeniaLawrence Rice, Walid K Attisha, Alane Drexler, et al.
International Journal of Hematology|November 22, 2005
Acute respiratory distress syndrome after rituximab infusionAlberto J Montero, John J McCarthy, George Chen, et al.
International Journal of Hematology|July 8, 2024
Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosisAkash Mukherjee, Cesar Gentille, Asmita Patel, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 9, 2019
Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance ReviewKartik Anand, Ethan A Burns, Joe Ensor, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|June 4, 2009
Changes of red blood cell surface markers in a blood doping model of neocytolysisChung-Che Chang, Yayan Chen, Kapil Modi, et al.
American Journal of Therapeutics|November 17, 2010
A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT StudySteven W Boyce, Dennis F Bandyk, John R Bartholomew, et al.
Journal of Intensive Care Medicine|March 16, 2006
Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospitalSandeep Kodityal, Phuong H Nguyen, Amith Kodityal, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 23, 2023
Interpreting coagulation mixing study results in the era of direct oral anticoagulantsMoon Joo Kim, Eric Salazar, Bonnie Philips, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
European Journal of Haematology|August 2, 2003
Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failuresSandeep Kodityal, Amit H Manhas, Mark Udden, et al.
Clinical Therapeutics|May 4, 2010
Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosisJames N Frame, Lawrence Rice, John R Bartholomew, et al.
Annals of Internal Medicine|February 6, 2002
Delayed-onset heparin-induced thrombocytopeniaLawrence Rice, Walid K Attisha, Alane Drexler, et al.
International Journal of Hematology|November 22, 2005
Acute respiratory distress syndrome after rituximab infusionAlberto J Montero, John J McCarthy, George Chen, et al.
International Journal of Hematology|July 8, 2024
Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosisAkash Mukherjee, Cesar Gentille, Asmita Patel, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 9, 2019
Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance ReviewKartik Anand, Ethan A Burns, Joe Ensor, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|June 4, 2009
Changes of red blood cell surface markers in a blood doping model of neocytolysisChung-Che Chang, Yayan Chen, Kapil Modi, et al.
American Journal of Therapeutics|November 17, 2010
A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT StudySteven W Boyce, Dennis F Bandyk, John R Bartholomew, et al.
Journal of Intensive Care Medicine|March 16, 2006
Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospitalSandeep Kodityal, Phuong H Nguyen, Amith Kodityal, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 23, 2023
Interpreting coagulation mixing study results in the era of direct oral anticoagulantsMoon Joo Kim, Eric Salazar, Bonnie Philips, et al.
Pageof 6